Medical device company Adherium and informatics company Summatix are teaming up to help clinicians provide the best possible care for people with asthma and chronic obstructive pulmonary disease (COPD).
Through this partnership, Adherium will gain access to Summatix’s regulated data platform to disseminate the data generated by its Hailie sensors for clinical purposes as well as other relevant uses.
“Adherium is excited to be partnering with Summatix in our continued efforts to deliver transformative asthma/COPD patient care,” Jeremy Curnock Cook, the company’s CEO, said in a press release.
Hailie sensors (formerly called Smartinhalers) attach to a patient’s asthma or COPD medication inhaler to monitor when it is being used, which can help ensure people take their medications as recommended. Using Summatix’s platform, this information can be shared with relevant parties, including patients, clinicians, insurers, and device manufacturers.
Additionally, Summatix’s proprietary Subjective Experience Data algorithm will allow physicians to get a more holistic picture of their patient’s health by using behavioral science technology to quantitatively evaluate how patients are feeling subjectively, in addition to objective measurements from the sensors.
The Summatix platform includes data security and privacy measures that are mandated by the U.S. Health Insurance Portability and Accountability Act (HIPAA) and the European Union’s General Data Protection Regulation (GDPR). It is also set to get the U.S. Food and Drug Administration’s Class I certification, which includes medical devices considered a low risk to patients.
“We are confident that when combined with the Summatix platform capabilities, Adherium’s Hailie solution will deliver significant advantages for patients, caregivers, doctors, and other health care providers in managing these costly diseases,” Cook said.
Adherium also announced a revamp of the Hailie app, including a “cloud-first architecture” that will make it easier to ensure that data privacy requirements are met and make the system more cost-effective.
The two companies are also planning to work together to make Hailie more accessible to patients, with reimbursement efforts focused in the United States, as well as in the European Union, United Kingdom, China, and Japan.
“It will also be a test case for providing U.S. clinicians with the means to access new remote monitoring reimbursement codes, using Summatix’s auditable reports to improve their workflow and deliver better care for their patients,” said Jeff Gross, CEO of Summatix.